TLR7 agonist 18 (Compound 21a) is a selective Toll-like receptor 7 (TLR7) agonist with an EC50 of 7.8 µM. TLR7 agonist 18 is not cytotoxic to hTLR7 cotransfected HEK293 cell lines and can induce the secretion of several cytokines, including IL-1beta, IL-12p70, IL-8, and TNF-alpha. TLR7 agonist 18 can be used in vaccine, asthma, allergy and anti-cancer research[1].
Molekulargewicht:
380.34
Formel:
C18H16F4N4O
Target-Kategorie:
Toll-like Receptor (TLR)
Anwendungsbeschreibung:
Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten